You will be leaving Lilly TrialGuide
You are now leaving the Lilly TrialGuide site. Eli Lilly and Company is not responsible for any content on the site you are about to visit.
A Study of LY900014 in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
Study Alias: ITRF
The purpose of this study is to investigate how the human body processes LY900014 and its effect on blood sugar levels when it is delivered via an insulin pump to participants with type 1 diabetes mellitus. Side effects and tolerability will be documented.
The results of this study are not yet available.
Here you can find out a bit more about the requirements for volunteers who took part in this study
Participants must have Type 1 Diabetes Mellitus (T1DM) and are receiving insulin therapy via an approved insulin pump
Participants must have a body mass index (BMI) of 18.5 to 33
Participants must have had no episodes of severe hypoglycemia in the past 6 months
Participants must not have had blood loss of more than 500 milliliters (mL) within the last month
Participants must not have previously participated or withdrawn from this study